Management of Suspected MRSA-Related Infectious Aortitis
This patient requires immediate initiation of prolonged intravenous anti-MRSA antibiotics (4-6 weeks minimum), urgent cardiothoracic surgical consultation for potential surgical debridement, and comprehensive imaging to define the extent of aortic involvement and exclude endocarditis.
Clinical Diagnosis
This presentation is highly concerning for infectious aortitis (also termed mycotic aortitis or infected aortic aneurysm) secondary to recent MRSA bacteremia. The combination of:
- Recent MRSA bacteremia with cardiac stent placement
- Persistent fever and systemic symptoms (cough, pleural effusions)
- Diffuse FDG uptake throughout the ascending, arch, and descending aorta
...strongly suggests hematogenous seeding of the aortic wall during the bacteremic episode 1.
Key pathophysiologic mechanism: Staphylococcus aureus is one of the two most common organisms causing infectious thoracic aortic aneurysms, and infection typically arises via hematogenous dissemination during bacteremia, particularly in patients with underlying atherosclerotic disease or recent cardiac procedures 1. The ascending thoracic aorta, aortic arch, and descending thoracic aorta can all be affected, and infected aneurysms may arise as late complications of cardiac surgery, often at sites of instrumentation 1.
Immediate Management Steps
1. Antimicrobial Therapy
Initiate prolonged IV anti-MRSA therapy immediately 2:
First-line options:
- IV vancomycin (dose-adjusted for renal function and trough levels 15-20 mcg/mL), OR
- Daptomycin 8-10 mg/kg IV once daily (higher doses recommended for complicated infections) 2
Duration: Minimum 4-6 weeks for complicated MRSA bacteremia with metastatic infection 2. Given the extensive aortic involvement, this patient meets criteria for complicated bacteremia requiring the longer duration.
Do NOT add rifampin or gentamicin to the primary regimen for bacteremia or vascular infection, as these combinations are not recommended 2.
2. Source Control Assessment
Comprehensive clinical assessment to identify and eliminate infection sources 2:
- Repeat blood cultures immediately and 2-4 days later to document clearance of bacteremia 2
- Transesophageal echocardiography (TEE) is mandatory to exclude endocarditis, particularly given the recent cardiac stent placement 2
- Evaluate the cardiac stent for infection—infected prosthetic material may require removal for source control 2
3. Surgical Consultation
Urgent cardiothoracic surgery consultation is essential 1:
- Infectious aortitis carries high mortality risk due to potential for rupture, aneurysm formation, or pseudoaneurysm development 1
- Surgical debridement and repair may be necessary, particularly if aneurysmal dilatation develops or if medical therapy fails 1
- The extensive involvement (ascending, arch, and descending aorta) makes this a complex surgical consideration requiring specialized expertise 1
4. Advanced Imaging
Obtain contrast-enhanced CT angiography (CTA) of the chest to:
- Define aortic wall thickness, presence of saccular or fusiform aneurysms, and pseudoaneurysm formation 1
- Assess for periaortic inflammation, abscess formation, or contiguous spread from adjacent structures (mediastinitis, empyema, infected lymph nodes) 1
- Establish baseline aortic dimensions for serial monitoring 1
The FDG-PET findings are diagnostic: FDG-PET has proven utility in detecting metastatic infections in MRSA bacteremia and can distinguish inflammatory from non-inflammatory aortic pathology 3, 4, 5. The diffuse uptake throughout the thoracic aorta confirms active infectious/inflammatory process 3, 4, 5.
Management of Pleural Effusions
Address bilateral pleural effusions which may represent:
- Parapneumonic effusion or empyema (requiring drainage if infected) 2
- Inflammatory effusion secondary to adjacent aortitis 1
Diagnostic thoracentesis should be performed to:
- Exclude empyema (which would require drainage in addition to antibiotics) 2
- Assess for other infectious or inflammatory etiologies 6
If empyema is confirmed, antimicrobial therapy must be used in conjunction with drainage procedures 2.
Critical Pitfalls to Avoid
Do not assume the bacteremia was truly "resolved" without repeat blood cultures—metastatic seeding may have occurred during the initial episode despite apparent clinical resolution 2, 3.
Do not treat with standard 2-week courses used for uncomplicated bacteremia—this patient has complicated bacteremia with metastatic vascular infection requiring 4-6 weeks minimum 2.
Do not delay surgical consultation—infectious aortitis can progress rapidly to rupture with catastrophic outcomes 1.
Do not overlook endocarditis—the recent cardiac stent and persistent symptoms mandate TEE evaluation 2.
Monitoring and Follow-up
- Serial blood cultures every 2-4 days until clearance documented 2
- Serial CTA imaging to monitor for aneurysm development or progression 1, 7
- Clinical response assessment including fever curve, inflammatory markers (CRP, ESR), and symptom resolution 2
- Consider repeat FDG-PET after treatment completion to assess treatment response, though this is not standard practice 3
Alternative Diagnostic Considerations
While infectious aortitis is most likely, the differential diagnosis for diffuse aortic FDG uptake includes:
- Large vessel vasculitis (giant cell arteritis)—however, this typically occurs in patients >50 years with different clinical features (headache, jaw claudication, vision changes), and the recent MRSA bacteremia makes infection far more likely 8, 9, 10, 11, 12
- Atherosclerotic inflammation—but this would not explain the acute febrile illness and recent bacteremia 1
The temporal relationship to MRSA bacteremia and acute presentation with fever strongly favor infectious etiology over vasculitis 1, 3, 4.